Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anixa Biosciences

3.23
+0.04001.25%
Post-market: 3.300.0700+2.17%15:57 EDT
Volume:38.26K
Turnover:123.37K
Market Cap:104.04M
PE:-8.56
High:3.39
Open:3.19
Low:3.19
Close:3.19
Loading ...
Jul 27, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jun 16, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 10, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
May 27, 2021

Major Issues Report

8-K - Current report
Apr 02, 2021

Major Issues Report

8-K - Current report
Mar 24, 2021

Major Issues Report

8-K - Current report
Mar 23, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 22, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Mar 11, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 05, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Jan 28, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 07, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 01, 2020

Major Issues Report

8-K - Current report
Sep 16, 2020

Major Issues Report

8-K - Current report
Sep 08, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 17, 2020

Major Issues Report

8-K - Current report
Jul 02, 2020

Major Issues Report

8-K - Current report
Jun 09, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]